These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 35213658)

  • 1. Preparation and evaluation of bilayer-core osmotic pump tablets contained topiramate.
    Lin W; Li Y; Shi Q; Liao X; Zeng Y; Tian W; Xie X; Liu H
    PLoS One; 2022; 17(2):e0264457. PubMed ID: 35213658
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preparation, release and pharmacokinetics of a risperidone elementary osmotic pump system.
    Gong W; Liu Y; Mei DY; Yang M; Mei XG
    Drug Dev Ind Pharm; 2015 Mar; 41(3):464-9. PubMed ID: 24400982
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preparation and
    Li N; Fan L; Wu B; Dai G; Jiang C; Guo Y; Wang D
    Drug Dev Ind Pharm; 2019 Jul; 45(7):1079-1088. PubMed ID: 30909753
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preparation, Characterization and in vivo Evaluation of Simple Monolithic Ethylcellulose-coated Pellets Containing Topiramate with Biphasic Release Characteristics.
    Gong W; Wang Y; Shao S; Xie S; Shan L; Yang M; Gao C; Zhong W
    Curr Drug Deliv; 2016; 13(2):245-54. PubMed ID: 26563941
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Development of glipizide push-pull osmotic pump controlled release tablets by using expert system and artificial neural network].
    Zhang ZH; Wang Y; Wu WF; Zhao X; Sun XC; Wang HQ
    Yao Xue Xue Bao; 2012 Dec; 47(12):1687-95. PubMed ID: 23460977
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Studies on bi-layer osmotic pump tablets of water-insoluble allopurinol with large dose: in vitro and in vivo.
    Wang X; Nie SF; Li W; Luan L; Pan W
    Drug Dev Ind Pharm; 2007 Sep; 33(9):1024-9. PubMed ID: 17891589
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A two-step strategy to design high bioavailable controlled-release nimodipine tablets: the push-pull osmotic pump in combination with the micronization/solid dispersion techniques.
    Liu X; Wang S; Chai L; Zhang D; Sun Y; Xu L; Sun J
    Int J Pharm; 2014 Jan; 461(1-2):529-39. PubMed ID: 24374219
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Controlled release of cyclosporine A self-nanoemulsifying systems from osmotic pump tablets: near zero-order release and pharmacokinetics in dogs.
    Zhang X; Yi Y; Qi J; Lu Y; Tian Z; Xie Y; Yuan H; Wu W
    Int J Pharm; 2013 Aug; 452(1-2):233-40. PubMed ID: 23688622
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preparation of a push-pull osmotic pump of felodipine solubilized by mesoporous silica nanoparticles with a core-shell structure.
    Wu C; Zhao Z; Zhao Y; Hao Y; Liu Y; Liu C
    Int J Pharm; 2014 Nov; 475(1-2):298-305. PubMed ID: 25148731
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Controlled release of metformin hydrochloride and repaglinide from sandwiched osmotic pump tablet.
    Qin C; He W; Zhu C; Wu M; Jin Z; Zhang Q; Wang G; Yin L
    Int J Pharm; 2014 May; 466(1-2):276-85. PubMed ID: 24607209
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sustained release formulation of Ondansetron HCl using osmotic drug delivery approach.
    Gundu R; Pekamwar S; Shelke S; Shep S; Kulkarni D
    Drug Dev Ind Pharm; 2020 Mar; 46(3):343-355. PubMed ID: 31937128
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Controlled release of ziprasidone solid dispersion systems from osmotic pump tablets with enhanced bioavailability in the fasted state.
    Yanfei M; Guoguang C; Lili R; Pingkai O
    Drug Dev Ind Pharm; 2015; 41(8):1353-62. PubMed ID: 25138348
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of controlled release osmotic pump tablet of glipizide solid dispersion.
    Patel GC; Asodaria KV; Patel HP; Shah DR
    Curr Drug Deliv; 2014; 11(6):817-27. PubMed ID: 23859357
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preparation of monolithic osmotic pump system by coating the indented core tablet.
    Liu L; Che B
    Eur J Pharm Biopharm; 2006 Oct; 64(2):180-4. PubMed ID: 16797951
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative steady-state pharmacokinetic evaluation of immediate-release topiramate and USL255, a once-daily extended-release topiramate formulation.
    Bialer M; Shekh-Ahmad T; Braun TL; Halvorsen MB
    Epilepsia; 2013 Aug; 54(8):1444-52. PubMed ID: 23692553
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Controlled release of glaucocalyxin - a self-nanoemulsifying system from osmotic pump tablets with enhanced bioavailability.
    Yanfei M; Guoguang C; Lili R; Pingkai O
    Pharm Dev Technol; 2017 Mar; 22(2):148-155. PubMed ID: 26400477
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Design push-pull osmotic pump tablets of famotidine based on an expert system for the formulation design of osmotic pump of poor water-soluble drug].
    Zhang ZH; Jin J; Zhang HW; Xin W; Jia GB; Wu WF; Pan WS
    Yao Xue Xue Bao; 2011 Jan; 46(1):109-14. PubMed ID: 21465816
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preparation of bilayer-core osmotic pump tablet by coating the indented core tablet.
    Liu L; Xu X
    Int J Pharm; 2008 Mar; 352(1-2):225-30. PubMed ID: 18068918
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Design and evaluation of in vivo bioavailability in beagle dogs of bilayer tablet consisting of immediate release nanosuspension and sustained release layers of rebamipide.
    Jin G; Ngo HV; Wang J; Cui JH; Cao QR; Park C; Jung M; Lee BJ
    Int J Pharm; 2022 May; 619():121718. PubMed ID: 35381311
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of monolithic osmotic pump tablet system for isosorbide-5-mononitrate delivery and evaluation of it in vitro and in vivo.
    Duan X; Liu Q; Zhang Y; Bi K; Chen X; Wang Y; Luo G
    Drug Dev Ind Pharm; 2009 Apr; 35(4):499-507. PubMed ID: 18979308
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.